Längin, Matthias
Mayr, Tanja
Reichart, Bruno
Michel, Sebastian
Buchholz, Stefan
Guethoff, Sonja
Dashkevich, Alexey
Baehr, Andrea
Egerer, Stefanie
Bauer, Andreas
Mihalj, Maks
Panelli, Alessandro
Issl, Lara
Ying, Jiawei
Fresch, Ann Kathrin
Buttgereit, Ines
Mokelke, Maren
Radan, Julia
Werner, Fabian
Lutzmann, Isabelle
Steen, Stig
Sjöberg, Trygve
Paskevicius, Audrius
Qiuming, Liao
Sfriso, Riccardo
Rieben, Robert
Dahlhoff, Maik
Kessler, Barbara
Kemter, Elisabeth
Kurome, Mayuko
Zakhartchenko, Valeri
Klett, Katharina
Hinkel, Rabea
Kupatt, Christian
Falkenau, Almuth
Reu, Simone
Ellgass, Reinhard
Herzog, Rudolf
Binder, Uli
Wich, Günter
Skerra, Arne
Ayares, David
Kind, Alexander
Schönmann, Uwe
Kaup, Franz-Josef
Hagl, Christian
Wolf, Eckhard
Klymiuk, Nikolai
Brenner, Paolo
Abicht, Jan-Michael
Article History
Received: 18 April 2018
Accepted: 2 November 2018
First Online: 5 December 2018
Change Date: 3 April 2019
Change Type: Correction
Change Details: In this Letter, Mayuko Kurome and Valeri Zakhartchenko have been added to the author list (affiliated with Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU Munich, Munich, Germany). The author list and ‘Author contributions’ section have been corrected online; see accompanying Amendment.
Competing interests
: D.A. is chief executive officer and chief scientific officer of Revivicor. Inc. A.S. and U.B. are cofounders of XL-protein GmbH, Germany. The other authors declare no competing interests.